Lack of combination effects of soy isoflavones and taxane chemotherapy of castration ‐resistant prostate cancer
The Prostate, EarlyView.
Source: The Prostate - Category: Urology & Nephrology Authors: Jillian N. Eskra,
Michael J. Schlicht,
Maarten C. Bosland Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Prostate Cancer | Soy isoflavones | Urology & Nephrology